Rotavirus-specific T cell responses and cytokine mRNA expression in children with diabetes-associated autoantibodies and type 1 diabetes

Clinical and Experimental Immunology

Volumn 145, Issue 2, 2006, Pages 261-270

  Makela M ^a   Oling V ^a   Marttila, J ^a   Waris, M ^a   Knip, M ^b,c   Simell, O ^a   Ilonen, J ^a,d  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Cytokine; Rotavirus; T cell proliferation; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; CYTOKINE; GAMMA INTERFERON; HLA ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 4; MESSENGER RNA; PHYTOHEMAGGLUTININ; TRANSFORMING GROWTH FACTOR BETA; TUBERCULIN; VIRUS ANTIBODY;

ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CELL ASSAY; CELL ISOLATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; COXSACKIE VIRUS B4; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTAVIRUS; T LYMPHOCYTE; VIRUS INFECTION; VIRUS PURIFICATION;

ANTIGENS, VIRAL; AUTOANTIBODIES; CASE-CONTROL STUDIES; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; CYTOKINES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INSULIN-SECRETING CELLS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; LINEAR MODELS; LYMPHOCYTE ACTIVATION; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ROTAVIRUS; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 33745938387     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03146.x     Document Type: Article

References (35)

1. Gianani R, Eisenbarth GS. The stages of type 1A diabetes: 2005. Immunol Rev 2005; 204:232-49.
2. Onkamo P, Väänänen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of Type I diabetes - the analysis of the data on published incidence trends. Diabetologia 1999; 42:1395-403.
3. Hermann R, Knip M, Veijola R et al. Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes - indication of an increased environmental pressure? Diabetologia 2003; 46:420-5.
4. Lammi N, Karvonen M, Tuomilehto J. Do microbes have a causal role in type 1 diabetes? Med Sci Monit 2005; 11: RA63-9.
5. Honeyman MC, Coulson BS, Stone NL et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 2000; 49:1319-24.
6. Coulson BS, Witterick PD, Tan Y et al. Growth of rotaviruses in primary pancreatic cells. J Virol 2002; 76:537-44.
7. Blomqvist M, Juhela S, Erkkilä S et al. Rotavirus infections and development of diabetes-associated autoantibodies during the first 2 years of life. Clin Exp Immunol 2002; 128:511-15.
8. Offit PA, Hoffenberg EJ, Santos N, Gouvea V. Rotavirus-specific humoral and cellular immune response after primary, symptomatic infection. J Infect Dis 1993; 167:1436-40.
9. Jaimes MC, Rojas OL, Gonzalez AM et al. Frequencies of virus-specific CD4(+) and CD8(+) T lymphocytes secreting gamma interferon after acute natural rotavirus infection in children and adults. J Virol 2002; 76:4741-9.
10. Rojas OL, Gonzalez AM, Gonzalez R et al. Human rotavirus specific T cells: quantification by ELISPOT and expression of homing receptors on CD4+ T cells. Virology 2003; 314:671-9.
11. Mäkelä M, Marttila J, Simell O, Ilonen J. Rotavirus-specific T-cell responses in young prospectively followed-up children. Clin Exp Immunol 2004; 137:173-8.
12. Roep BO. The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure. Diabetologia 2003; 46:305-21.
13. Kupila A, Muona P, Simell T et al. Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort. Diabetologia 2001; 44:290-7.
14. Abraham G, Colonno RJ. Many rhinovirus serotypes share the same cellular receptor. J Virol 1984; 51:340-5.
15. Stordeur P, Poulin LF, Craciun L et al. Cytokine mRNA quantification by real-time PCR. J Immunol Meth 2002; 259:55-64.
16. Halminen M, Sjöroos M, Mäkelä MJ et al. Simultaneous detection of IFN-gamma and IL-4 mRNAs using RT-PCR and time-resolved fluorometry. Cytokine 1999; 11:87-93.
17. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Meth Mol Biol 2000; 132:365-86.
18. Savola K, Sabbah E, Kulmala P, Vähäsalo P, Ilonen J, Knip M. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children. Diabetologia 1998; 41:1293-7.
19. Savola K, Bonifacio E, Sabbah E et al. IA-2 antibodies - a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes Finland Study Group. Diabetologia 1998; 41:424-9.
20. Williams AJ, Bingley P, Bonifacio E, Palmer JP, Gale EA. A novel micro-assay for insulin autoantibodies. J Autoimmun 1997; 10:473-8.
21. Jones DB, Crosby I. Proliferative lymphocyte responses to virus antigens homologous to GAD65 in IDDM. Diabetologia 1996; 39:1318-24.
22. Hyöty H. Enterovirus infections and type 1 diabetes. Ann Med 2002; 34:138-47.
23. Honeyman MC, Stone NL, Harrison LC. T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents. Mol Med 1998; 4:231-9.
24. Maunula L, von Bonsdorff CH. Frequent reassortments may explain the genetic heterogeneity of rotaviruses: analysis of Finnish rotavirus strains. J Virol 2002; 76:11793-800.
25. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005; 15:29-56.
26. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995; 80:695-705.
27. Maverakis E, van den Elzen P, Sercarz EE. Self-reactive T cells and degeneracy of T cell recognition: evolving concepts-from sequence homology to shape mimicry and TCR flexibility. J Autoimmun 2001; 16:201-9.
28. Juhela S, Hyöty H, Hinkkanen A et al. T cell responses to enterovirus antigens and to beta-cell autoantigens in unaffected children positive for IDDM-associated autoantibodies. J Autoimmun 1999; 12:269-78.
29. Juhela S, Hyöty H, Roivainen M et al. T-cell responses to enterovirus antigens in children with type 1 diabetes. Diabetes 2000; 49:1308-13.
30. Halminen M, Juhela S, Vaarala O, Simell O, Ilonen J. Induction of interferon-gamma and IL-4 production by mitogen and specific antigens in peripheral blood lymphocytes of Type 1 diabetes patients. Autoimmunity 2001; 34:1-8.
31. Kallmann BA, Huther M, Tubes M et al. Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease. Diabetes 1997; 46:237-43.
32. Kretowski A, Maciej K, Ida K. The analysis of in vitro transforming growth factor-beta1 (TGF-beta1) production by peripheral blood in overt and pre-clinical type 1 diabetes mellitus. Immunol Lett 2000; 71:85-9.
33. Berman MA, Sandborg CI, Wang Z et al. Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus. J Immunol 1996; 157:4690-6.
34. Lohmann T, Laue S, Nietzschmann U et al. Reduced expression of Th1-associated chemokine receptors on peripheral blood lymphocytes at diagnosis of type 1 diabetes. Diabetes 2002; 51:2474-80.
35. Rapoport MJ, Mor A, Vardi P et al. Decreased secretion of Th2 cytokines precedes Up-regulated and delayed secretion of Th1 cytokines in activated peripheral blood mononuclear cells from patients with insulin-dependent diabetes mellitus. J Autoimmun 1998; 11:635-42.